J&J receives FDA approval for lung cancer therapy
The approval is supported by results from the Phase III PALOMA-3 study.
Drug Development
EC approves Incyte’s Minjuvi combo for follicular lymphoma
Alnylam plans $250m investment in Norton manufacturing facility, US
Harbour BioMed and BMS sign multi-specific antibody collab
INCOG reveals $200m injectable drug expansion in Indiana
States consider payment limits to curb prescription drug prices with PDABs
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
SK Capital Partners supports Swixx BioPharma’s global expansion
